Drug law reform continues developing in the right direction in several Latin American and Caribbean countries. In Jamaica, for example, a law legalizing the cultivation and consumption of ganja for medicinal, religious and research purposes came into force, as well as the decriminalisation of possession for personal use. Jamaica also spoke out at the UN Thematic Debate in New York. On May 7th, the minister addressed the UN High Level Thematic Debate on international drug policy, highlighting Jamaica’s perspectives on drug control policies and participating in a debate that encourages open and inclusive discussions. Amongst the outcomes Jamaica would like to see from UNGASS is “the establishment of an Expert Advisory Group to review the UN drug policy control architecture, its system-wide coherence, its treaty inconsistencies and its legal tension with cannabis regulations.”
As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.
State-level cannabis reforms have exposed the inability of the United States to abide by the terms of the legal bedrock of the global drug control system. It is calls for a conversation the US federal government wishes to avoid. The result is a new official position on the UN drugs treaties that, despite its seductively progressive tone, serves only to sustain the status quo and may cause damage beyond drug policy.
David Bewley Taylor is the founding Director of the Global Drug Policy Observatory at Swansea University, UK. He has been researching various aspects of drug policy for over twenty years with his main areas of interest being US drug policy, the UN and international drug policy and more recently counter narcotics strategies in Afghanistan....
David Bewley-Taylor, Martin Jelsma, Christopher Hallam
16 June 2014
Scheduling is mostly prioritised in its repressive pole, though present debates are increasingly highlighting the need to modify the balance of the system in order to affirm the importance of the principle of health.
Ann Fordham of the International Drug Policy Consortium (IDPC) delivered the NGO Statement to CND Plenary under Item 8: Preparations for the high-level review of the implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem.
Since 1909 the international community has worked to eradicate the abuse of narcotics. A century on, the efforts are widely acknowledged to have failed, and worse, have spurred black market violence and human rights abuses. How did this drug control system arise, why has it proven so durable in the face of failure, and is there hope for reform?
The last of the four ‘round tables’ of the high-level segment of the Commission on Narcotic Drugs was devoted to the broad issue of Countering illicit drug traffic and supply, and alternative development. TNI had been nominated by the Vienna NGO Committee to give a statement on the issue of Alternative Development (AD), being one of the few member NGOs with a track record on this issue and having actively participated in the Beyond 2008 initiative, including the negotiations at the July NGO forum to reach consensus on the text of a paragraph on AD in the final declaration. This is our impression of the event.
Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
15 March 2009
This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.
Prohibitionist policies based on the eradication of production and on the disruption of drug flows as well as on the criminalization of consumption have not yielded the desired results. We are further than ever from the announced goal of eradicating drugs.
Breaking the taboo, acknowledging the failure of current policies and their consequences is the inescapable prerequisite for the discussion of a new paradigm leading to safer, more efficient and humane drug policies.
The Latin American Commission on Drugs and Democracy presented its conclusions at a press conference in Rio de Janeiro, on 11 February. Founded by former Presidents Fernando Henrique Cardoso (Brazil), César Gaviria (Colombia) and Ernesto Zedillo (Mexico), integrated by 17 independent members, the Commission assessed the limits and unwanted effects of the repressive policies of the "war on drugs" in Latin America.
On October 2, 2008, the Beckley Foundation launched in the House of Lords its Global Cannabis Commission Report, an authoritative guide to the effects of cannabis, the policies that control its use, and recommendations for policy reform. A team of leading drug policy analysts prepared an overview of the latest scientific evidence surrounding cannabis and the policies that control its use.
On thursday 28 February 2008 the Dutch Parliamentary Justice Commission devoted its debate to the drugs UNGASS review. Martin Jelsma was invited as one of the experts to share with the commission TNI's views on the importance of the review process. In his contribution he highlights the opportunity to use the 2008/9 period to achieve a breakthrough on harm reduction acceptance at the UN level, to evaluate the performance of UN agencies like UNODC and the INCB, and to open the door for a revision of the UN drug control treaty system. only available in Dutch
TNI co-signed a letter that was sent to the Dutch Prime Minister and relevant parliamentary commissions, stressing the need for an active Dutch involvement in the UNGASS review process and specifically to use the moment to open the discussion about the UN conventions that are an obstacle to further developments in Dutch cannabis policy.
Martin Jelsma is a political scientist who has specialised in Latin America and international drugs policy. In 2005, he received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship, which stated that Jelsma "is increasingly recognized as one of, if not the, outstanding strategists in terms of how international institutions deal with drugs and drug policy."...
Pien Metaal is a researcher with TNI. She holds a Master of Arts Degree in Political Science and International Relations from University of Amsterdam. She has been a member of the Transnational Institute's Drugs and Democracy team since 2002, though her participation with the Programme dates further back....
Tom Blickman is a Senior Project Officer at the Transnational Institute (TNI), based in Amsterdam. Since 1997, he has been working for TNI's Drugs & Democracy Programme, specializing in international drug control policy and the UN conventions, drug markets, alternative development, money laundering and organised crime. Tom is a regular speaker at international policy conferences and advises...
Ernestien Jensema (1971) is a social anthropologist who has been working as a researcher and project coordinator with the Drugs & Democracy Programme of TNI since 2008. She focuses on issues related to the UN drug control system and the Drugs and Democracy Programme’s Asia project....